PDEδ interference impedes the proliferation and survival of oncogenic KRas expressing human cancer cell lines
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Dortmund, Technische Universität, Dissertation, 2019
- Schlagwort
-
Cancer
Cell lines
Survival
Krebs
Medizin
- Ereignis
-
Veröffentlichung
- (wo)
-
Dortmund
- (wer)
-
Universitätsbibliothek Dortmund
- (wann)
-
2018
- Urheber
- Beteiligte Personen und Organisationen
-
Bastiaens, Philippe
Dehmelt, Leif
- Handle
-
2003/38045
- URN
-
urn:nbn:de:101:1-2019051703422201162960
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:43 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Klein, Christian H.
- Bastiaens, Philippe
- Dehmelt, Leif
- Universitätsbibliothek Dortmund
Entstanden
- 2018
Ähnliche Objekte (12)
Immune modulatory effects of oncogenic KRAS in cancer
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Oncogenic KRAS renders cells resistant to ferroptosis by upregulating FSP1
Oncogenic KrasG12D causes myeloproliferation in leukaemia via NLRP3 inflammasome activation
The role of oncogenic Kras signaling in the non-hematopoietic bone marrow microenvironment
"KRAS
Kras
Cell type-dependent differential activation of ERK by oncogenic KRAS or BRAF in the mouse intestinal epithelium
HDAC Inhibitor-Induced acetylation of KRAS confers a pro-oncogenic effect limiting treatment response in colorectal cancer
Downstream Signaling of Oncogenic Kras in Pancreatic Ductal Adenocarcinoma : In Vivo and Ex Vivo Imaging of Tumor Cell Proliferation as a Tool for the Identification of Therapeutic Targets
Downstream signaling of oncogenic Kras in pancreatic ductal adenocarcinoma : in-vivo- and ex-vivo-imaging of tumor cell proliferation as a tool for the identification of therapeutic targets
Immune modulatory effects of oncogenic KRAS in cancer
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Oncogenic KRAS renders cells resistant to ferroptosis by upregulating FSP1
Oncogenic KrasG12D causes myeloproliferation in leukaemia via NLRP3 inflammasome activation
The role of oncogenic Kras signaling in the non-hematopoietic bone marrow microenvironment
"KRAS
Kras
Cell type-dependent differential activation of ERK by oncogenic KRAS or BRAF in the mouse intestinal epithelium
HDAC Inhibitor-Induced acetylation of KRAS confers a pro-oncogenic effect limiting treatment response in colorectal cancer
Downstream Signaling of Oncogenic Kras in Pancreatic Ductal Adenocarcinoma : In Vivo and Ex Vivo Imaging of Tumor Cell Proliferation as a Tool for the Identification of Therapeutic Targets
Downstream signaling of oncogenic Kras in pancreatic ductal adenocarcinoma : in-vivo- and ex-vivo-imaging of tumor cell proliferation as a tool for the identification of therapeutic targets
Immune modulatory effects of oncogenic KRAS in cancer
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Oncogenic KRAS renders cells resistant to ferroptosis by upregulating FSP1
Oncogenic KrasG12D causes myeloproliferation in leukaemia via NLRP3 inflammasome activation
The role of oncogenic Kras signaling in the non-hematopoietic bone marrow microenvironment
"KRAS
Kras
Cell type-dependent differential activation of ERK by oncogenic KRAS or BRAF in the mouse intestinal epithelium
HDAC Inhibitor-Induced acetylation of KRAS confers a pro-oncogenic effect limiting treatment response in colorectal cancer
Downstream Signaling of Oncogenic Kras in Pancreatic Ductal Adenocarcinoma : In Vivo and Ex Vivo Imaging of Tumor Cell Proliferation as a Tool for the Identification of Therapeutic Targets